|
Volumn 47, Issue 7, 2007, Pages 993-995
|
NIH funding for research on headache disorders: Does it matter?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALMOTRIPTAN;
ELETRIPTAN;
ETIRACETAM;
FELBAMATE;
FOSPHENYTOIN SODIUM;
FROVATRIPTAN;
GABAPENTIN;
LAMOTRIGINE;
NARATRIPTAN;
OXCARBAZEPINE;
PREGABALIN;
RIZATRIPTAN;
SUMATRIPTAN;
TIAGABINE;
TOPIRAMATE;
ZOLMITRIPTAN;
ZONISAMIDE;
ARTICLE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG SCREENING;
EPILEPSY;
FOOD AND DRUG ADMINISTRATION;
HEADACHE AND FACIAL PAIN;
HUMAN;
MEDICAL RESEARCH;
MIGRAINE;
NONHUMAN;
PRIORITY JOURNAL;
EPILEPSY;
HEADACHE;
HUMANS;
MIGRAINE DISORDERS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
RESEARCH SUPPORT;
UNITED STATES;
|
EID: 34447311074
PISSN: 00178748
EISSN: 15264610
Source Type: Journal
DOI: 10.1111/j.1526-4610.2007.00875.x Document Type: Article |
Times cited : (8)
|
References (8)
|